(19)
(11) EP 4 240 853 A2

(12)

(88) Date of publication A3:
16.06.2022

(43) Date of publication:
13.09.2023 Bulletin 2023/37

(21) Application number: 21815788.1

(22) Date of filing: 03.11.2021
(51) International Patent Classification (IPC): 
C12N 15/113(2010.01)
C12N 15/90(2006.01)
C12N 15/10(2006.01)
C12N 9/22(2006.01)
(52) Cooperative Patent Classification (CPC):
C12N 9/22; C12N 15/113; C12N 2310/20; C12N 15/902
(86) International application number:
PCT/US2021/057798
(87) International publication number:
WO 2022/098681 (12.05.2022 Gazette 2022/19)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 03.11.2020 US 202063109302 P

(71) Applicant: Science Solutions LLC
San Francisco, CA 94103 (US)

(72) Inventors:
  • GIMENEZ, Carla Alejandra
    San Francisco, CA 94103 (US)
  • LARA, Maria Julia
    San Francisco, CA 94103 (US)

(74) Representative: V.O. 
P.O. Box 87930
2508 DH Den Haag
2508 DH Den Haag (NL)

   


(54) NOVEL CLASS 2 CRISPR-CAS RNA-GUIDED ENDONUCLEASES